Franklin Genomic Advancements ETF (HELX) Volatility Skew
Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.
Franklin Genomic Advancements ETF (HELX) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $16.9M, listed on CBOE, carrying a beta of 1.02 to the broader market. The fund seeks capital appreciation by investing in equity securities inside and outside of the United States, including developing or emerging markets. public since 2020-02-27.
Snapshot as of May 15, 2026.
- Spot Price
- $32.94
- ATM IV
- 32.6%
- IV Skew 25Δ
- 0.019
- IV Rank
- 4.4%
- IV Percentile
- 15.1%
- Term Structure Slope
- -0.023
As of May 15, 2026, Franklin Genomic Advancements ETF (HELX) at-the-money implied volatility is 32.6%. IV rank is 4.4% (where 0% is the 52-week low and 100% is the 52-week high). IV percentile is 15.1%. The 25-delta skew is +0.019: skew is roughly flat across the 25-delta wings. High IV rank typically favors premium-selling strategies; low IV rank favors premium-buying.
HELX Strategy Selection at Current Volatility Levels
For Franklin Genomic Advancements ETF options at 32.6% ATM IV, low IV rank (4.4%) favors premium-buying or long-vol structures: long calls or puts, debit spreads, calendar spreads, long straddles. The risk: low-rank regimes can persist for months while time decay eats premium-buyers alive. Pair the vol-rank read with the dealer-gamma view and the upcoming-events calendar to confirm the strategy fits both the structural regime and the path-dependent risk. The variance risk premium - the persistent gap between implied and subsequently realized vol - is positive in equity markets on average; high IV rank typically reflects a stretch where the premium is wider than usual.
Learn how volatility skew is reported and how to read the data →
Frequently asked HELX volatility skew questions
- What is the current HELX ATM implied volatility?
- As of May 15, 2026, Franklin Genomic Advancements ETF (HELX) at-the-money implied volatility is 32.6%. IV rank is 4.4% on a 0-100% scale anchored to the 1-year IV range. ATM IV is the volatility input that makes a Black-Scholes-equivalent model reproduce the listed at-the-money option prices.
- Is HELX IV high or low historically?
- IV is subdued relative to its 1-year history, conditions that typically favor premium-buying strategies (long calls, long puts, debit spreads, calendar spreads).
- What does HELX volatility skew tell options traders?
- Volatility skew is the pattern by which IV varies across strikes for a given expiration. Franklin Genomic Advancements ETF skew is roughly flat across the 25-delta wings. Skew matters for risk-defined strategy selection: when downside puts are rich, put-credit spreads capture more premium; when upside calls are rich, call-credit spreads or covered-call writes harvest more.